Three Possible Paths to Targeting Undruggable Transcripton Factors
Originally recorded July 22, 2021
William G. Kaelin Jr., MD
Harvard Medical School
Dana-Farber Cancer Institute
Introduction by
Anand Patel, MD, PhD
Department of Oncology
Comprehensive Cancer Center
St. Jude Children's Research Hospital